A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma.
David QuallsHiu Ying LamKarissa A WhitingAnita KumarMatthew MatasarColette OwensChelsea NicholsJames A EspeletaAnnie QiuSarima SubzwariErin BiggarVenkatraman SeshanGilles Andre SallesAnas YounesConnie Lee BatleviPublished in: Blood advances (2022)